trial · primary record
Surgical resection
Adrenocortical Carcinoma (ACC)
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 32 |
| Primary completion | 2040-12-01 |
| Primary endpoint | Determine the maximum tolerated dose (MTD) and safety and toxicity profile of preoperative external beam radiation therapy (RT) with or without standard-of-care mitotane, before surgical resection in participants with resectable recurrent ACC |
| Registry ID | NCT06487481 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:31:52.596Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06487481
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.